March 3, 2026Open Access

Cardiovascular Outcomes in COVID-19 Patients Treated with Paxlovid: A Multicenter Retrospective Study.

Key Points

Paxlovid treatment is associated with improved short-term survival in COVID-19 patients, alongside increased venous thromboembolism risk.
Approximately 20% of patients treated experienced some form of thromboembolic complication during the study period.
Retrospective analysis evaluated cardiovascular outcomes across multiple healthcare centers, assessing patient records systematically.
These findings highlight the importance of careful patient selection and monitoring, particularly for those at risk.

Abstract

While Paxlovid treatment resulted in significant short-term survival improvements among COVID-19 patients, it was also associated with a higher incidence of venous thromboembolic complications. These findings highlight the need for careful patient selection and monitoring, particularly for those with preexisting cardiovascular conditions.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Wei-Lun Chen

Victor Chien-Chia Wu

Chun-Li Wang

Actions

Institutions

Chang Gung University

Chang Gung Memorial Hospital

Chang Gung University of Science and Technology

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cardiovascular Outcomes in COVID-19 Patients Treated with Paxlovid: A Multicenter Retrospective Study.

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study